首页> 外文期刊>The American Journal of Human Genetics >Excess of de novo deleterious mutations in genes associated with glutamatergic systems in nonsyndromic intellectual disability.
【24h】

Excess of de novo deleterious mutations in genes associated with glutamatergic systems in nonsyndromic intellectual disability.

机译:非综合征性智力障碍中与谷氨酸能系统相关基因的从头有害突变过多。

获取原文
获取原文并翻译 | 示例
       

摘要

Little is known about the genetics of nonsyndromic intellectual disability (NSID). We hypothesized that de novo mutations (DNMs) in synaptic genes explain an important fraction of sporadic NSID cases. In order to investigate this possibility, we sequenced 197 genes encoding glutamate receptors and a large subset of their known interacting proteins in 95 sporadic cases of NSID. We found 11 DNMs, including ten potentially deleterious mutations (three nonsense, two splicing, one frameshift, four missense) and one neutral mutation (silent) in eight different genes. Calculation of point-substitution DNM rates per functional and neutral site showed significant excess of functional DNMs compared to neutral ones. De novo truncating and/or splicing mutations in SYNGAP1, STXBP1, and SHANK3 were found in six patients and are likely to be pathogenic. De novo missense mutations were found in KIF1A, GRIN1, CACNG2, and EPB41L1. Functional studies showed that all these missense mutations affect protein function in cell culture systems, suggesting that they may be pathogenic. Sequencing these four genes in 50 additional sporadic cases of NSID identified a second DNM in GRIN1 (c.1679_1681dup/p.Ser560dup). This mutation also affects protein function, consistent with structural predictions. None of these mutations or any other DNMs were identified in these genes in 285 healthy controls. This study highlights the importance of the glutamate receptor complexes in NSID and further supports the role of DNMs in this disorder.
机译:关于非综合征性智力障碍(NSID)的遗传学知之甚少。我们假设突触基因中的从头突变(DNM)解释了零星NSID病例的重要组成部分。为了调查这种可能性,我们对95个散发的NSID病例中的197个编码谷氨酸受体及其大量相互作用蛋白的基因进行了测序。我们发现了11个DNM,包括八个不同基因中的10个潜在有害突变(三个无意义,两个剪接,一个移码,四个错义)和一个中性突变(沉默)。与中性位点相比,每个功能位点和中性位点的点替代DNM率的计算显示功能性DNM明显过量。在6例患者中发现了SYNGAP1,STXBP1和SHANK3的从头截短和/或剪接突变,可能具有致病性。在KIF1A,GRIN1,CACNG2和EPB41L1中发现了从头错义突变。功能研究表明,所有这些错义突变都会影响细胞培养系统中的蛋白质功能,表明它们可能是致病的。在另外50个NSID散发病例中对这四个基因进行测序,确定了GRIN1中的第二个DNM(c.1679_1681dup / p.Ser560dup)。该突变也影响蛋白质功能,与结构预测一致。在285个健康对照的这些基因中,没有发现这些突变或任何其他DNM。这项研究突出了谷氨酸受体复合物在NSID中的重要性,并进一步支持了DNM在这种疾病中的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号